Bausch + Lomb (BLCO) News Today → The only AI company to buy (From Porter & Company) (Ad) Free BLCO Stock Alerts $15.26 +0.24 (+1.60%) (As of 02:04 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 9:08 AM | finance.yahoo.comBausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®May 28 at 6:59 AM | businesswire.comBausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular LensMay 28 at 12:17 AM | markets.businessinsider.comBausch + Lomb: Strong Sales and Market Share Growth Justify Buy RatingMay 25 at 2:48 AM | americanbankingnews.comBausch + Lomb Co. (NYSE:BLCO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 25 at 2:44 AM | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Average Rating of "Moderate Buy" by BrokeragesBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven brokerages that are currently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and six have issued aMay 24, 2024 | seekingalpha.comBausch + Lomb's Bet-The-Farm Xiidra Acquisition Is Looking Questionable, But Miebo Could Make The Stock A WinnerMay 22, 2024 | seekingalpha.comBausch + Lomb Corporation: Spin-Off Ready To Fly Troubled Nest And Find UpsideMay 21, 2024 | uk.finance.yahoo.comBHC May 2024 7.000 putMay 21, 2024 | uk.finance.yahoo.comBHC Sep 2024 4.000 callMay 21, 2024 | theglobeandmail.comClosing Bell: Bausch Lomb Corporation flat on Tuesday (BLCO)May 20, 2024 | markets.businessinsider.comStrong Performance and Positive Outlook for Bausch + Lomb Corporation Affirm Buy RatingMay 16, 2024 | marketbeat.comJump Financial LLC Raises Position in Bausch + Lomb Co. (NYSE:BLCO)Jump Financial LLC increased its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 478.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,100 shares of the company's stock after purchasing aMay 7, 2024 | msn.comMorgan Stanley Upgrades Bausch + Lomb (BLCO)May 6, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Shares Gap Up to $13.60Bausch + Lomb (NYSE:BLCO) Shares Gap Up to $13.60May 6, 2024 | msn.comMorgan Stanley upgrades Bausch + Lomb, cites improving marginsMay 6, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Upgraded to Overweight at Morgan StanleyMorgan Stanley raised Bausch + Lomb from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $16.00 to $18.00 in a research note on Monday.May 4, 2024 | theglobeandmail.comBausch & Lomb: Top 10 Undervalued Growth Stocks on TSX (BLCO)May 3, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Bausch + Lomb Co. Issued By HC Wainwright (NYSE:BLCO)Bausch + Lomb Co. (NYSE:BLCO - Free Report) - Stock analysts at HC Wainwright lifted their Q2 2024 EPS estimates for shares of Bausch + Lomb in a report issued on Thursday, May 2nd. HC Wainwright analyst Y. Chen now expects that the company will post earnings of $0.20 per share for the quarter, uMay 3, 2024 | finance.yahoo.comBausch + Lomb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 3, 2024 | msn.comBausch + Lomb recalls Project Watson dog eye wipes due to risk of bacteria, fungus exposureMay 3, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)May 2, 2024 | markets.businessinsider.comRobust Start and Organic Growth Affirm Bausch + Lomb’s Buy RatingMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Bausch + Lomb: Strong Q1 Performance and Promising Growth Outlook Despite FX HeadwindsMay 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) PT Lowered to $15.00 at EvercoreEvercore cut their target price on shares of Bausch + Lomb from $17.00 to $15.00 and set an "in-line" rating for the company in a research note on Thursday.May 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Hits New 1-Year Low After Earnings MissBausch + Lomb (NYSE:BLCO) Reaches New 52-Week Low on Disappointing EarningsMay 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Posts Earnings Results, Misses Expectations By $0.02 EPSBausch + Lomb (NYSE:BLCO - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.02). Bausch + Lomb had a positive return on equity of 3.70% and a negative net margin of 6.27%. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the company earned $0.10 EPS. The company's revenue for the quarter was up 18.0% on a year-over-year basis.May 2, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $20.00 target price on shares of Bausch + Lomb in a research note on Thursday.May 2, 2024 | gurufocus.comQ1 2024 Bausch + Lomb Corp Earnings Call TranscriptMay 1, 2024 | marketwatch.comBausch + Lomb Quarterly Loss WidensMay 1, 2024 | businesswire.comBausch + Lomb Announces First-Quarter 2024 ResultsApril 30, 2024 | marketbeat.comShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Expands By 8.7%Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,630,000 shares, an increase of 8.7% from the March 31st total of 1,500,000 shares. Based on an average daily trading volume, of 464,700 shares, the days-to-cover ratio is currently 3.5 days. Approximately 4.3% of the shares of the company are short sold.April 30, 2024 | msn.comBausch + Lomb Q1 2024 Earnings PreviewApril 30, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of "Moderate Buy" by BrokeragesBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has earned an average recommendation of "Moderate Buy" from the ten brokerages that are covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the coApril 29, 2024 | businesswire.comBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual MeetingApril 25, 2024 | msn.comBausch + Lomb reports positive study results for Blink NutriTearsApril 25, 2024 | businesswire.comBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry EyesApril 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Edgewise Therapeutics (EWTX)April 22, 2024 | marketbeat.comRoyal Bank of Canada Cuts Bausch + Lomb (NYSE:BLCO) Price Target to $18.00Royal Bank of Canada cut their target price on Bausch + Lomb from $20.00 to $18.00 and set an "outperform" rating on the stock in a research note on Monday.April 18, 2024 | finance.yahoo.comBausch + Lomb Corporation (BLCO)April 18, 2024 | businesswire.comBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsApril 17, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Purchased by River Road Asset Management LLCRiver Road Asset Management LLC boosted its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 21.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,938,207 shares of the company's stock aApril 15, 2024 | businesswire.comBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1April 11, 2024 | msn.comBausch Health gains after appeals court affirms ruling in Norwich patent case (update)April 11, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) Sees Unusually-High Trading VolumeBausch + Lomb (NYSE:BLCO) Sees Unusually-High Trading VolumeApril 9, 2024 | markets.businessinsider.comBausch + Lomb’s Strong Market Position and Innovative Pipeline Justify Buy RatingApril 4, 2024 | marketbeat.comBausch + Lomb (NYSE:BLCO) PT Raised to $17.00 at Evercore ISIEvercore ISI boosted their target price on Bausch + Lomb from $16.50 to $17.00 and gave the stock an "in-line" rating in a report on Thursday.April 2, 2024 | markets.businessinsider.comBausch + Lomb’s Strong Position in Dry Eye Market Prompts Buy RatingMarch 30, 2024 | marketbeat.comShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Decreases By 20.1%Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,230,000 shares, a drop of 20.1% from the February 29th total of 1,540,000 shares. Based on an average daily volume of 449,000 shares, the short-interest ratio is currently 2.7 days. Approximately 3.2% of the company's stock are sold short.March 29, 2024 | nasdaq.comBLCO Crosses Above Key Moving Average LevelMarch 16, 2024 | finance.yahoo.comBLCO Apr 2024 17.500 call Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now BLCO Media Mentions By Week BLCO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.290.92▲Average Medical News Sentiment BLCO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼113▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RxSight News Today STAAR Surgical News Today Warby Parker News Today Cooper Companies News Today Apellis Pharmaceuticals News Today Madrigal Pharmaceuticals News Today Option Care Health News Today Doximity News Today Ionis Pharmaceuticals News Today Merit Medical Systems News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWARNING about the death of the U.S. dollar…Colonial MetalsThe only AI company to buyPorter & CompanyBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsPresident Biden just made a shocking moveStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
